Apomorphine Pump for Late-Stage Parkinson's at End of Life
Part of Brain & nervous system clinical trials.
This trial studies whether a continuous apomorphine pump can help people with advanced Parkinson's disease who can no longer take oral medications and are receiving palliative care. The pump delivers medicine under the skin to manage symptoms when other treatments are no longer possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced Parkinson's disease and your doctor has said a pump with apomorphine could be an option
- You are receiving palliative (comfort-focused) care
- You can no longer take medications by mouth
- You must be able to consent, or have a trusted person who can consent for you
- Your symptoms are severe and affect both sides of your body even when off medication
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at real-world experiences of people with Parkinson's who are using ONAPGO, a medication given continuously under the skin through a pump. The goal is to understand how this treatment works in daily life.
This trial tests whether using a wearable device and patient questionnaires can help doctors decide who should get advanced Parkinson's treatments like pump therapies or deep brain stimulation. It aims to make referral decisions more accurate and timely.
This study looks at how patients start and adjust a new medicine (sublingual apomorphine, or SL-APO) for Parkinson's disease OFF episodes. OFF episodes are times when Parkinson's symptoms come back between medicine doses. If you are about to start SL-APO for the first time, this trial may be a good fit.
This study is looking at how a new continuous 24-hour injection treatment (foslevodopa/foscarbidopa) affects quality of life in people with advanced Parkinson's disease. It is a real-world study, meaning you just take the medication as your doctor prescribes, and researchers observe the results.
This early-phase trial tests how safe and potentially effective KL002 is for people with advanced Parkinson’s disease. It may help reduce Parkinson’s movement symptoms, but the main early goal is safety.
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.